LION
Live / Applied — Second extension granted (statement of use) (as of 23 Jun 2026)
What this means for you
Not registered yet, but its 01 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97979216
- Mark type
- Stylized text
- Filed
- 01 Sept 2022
- Published for opposition
- 14 Jan 2025
- Attorney of record
- Draeke H. Weseman
Goods and services
- Class 005 — Pharmaceuticals: Nanoparticle formulations as components of RNA-based vaccines, namely, RNA drug delivery agents consisting of biologically active compositions in the form of cationic nanoparticles that facilitate the delivery of RNA to biological cells; Nanoparticle formulations as components of RNA-based vaccines, namely, RNA drug delivery agents consisting of cationic nanoparticle emulsions that facilitate the delivery of RNA to biological cells; Drug delivery agents consisting of emulsions that facilitate delivery of RNA-based vaccines, namely delivery of RNA to biological cells for the prevention of infectious diseases
Owner
- HDT Bio Corp., Seattle, WA, US
- HDT Bio Corp., Seattle, WA, US
Prosecution history
- 10 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 24 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2026 — SOU EXTENSION 2 GRANTED
- 03 Mar 2026 — SOU EXTENSION 2 FILED
- 22 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2026 — SOU EXTENSION 1 GRANTED
- 10 Sept 2025 — SOU EXTENSION 1 FILED
- 10 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jan 2025 — PUBLISHED FOR OPPOSITION
- 08 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER